SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
momo-T/FIF
An SI Board Since October 2003
Posts SubjectMarks Bans
12215 138 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
12140I come up with nothing for chbr.scaram(o)uche-1/17/2019
12139Hughes is gone. Good! Yeah, walked into this one with eyes wide open.scaram(o)uche-1/17/2019
12138All three posters (Prader-Willi) are here........ zafgen.com And the presentatscaram(o)uche-1/17/2019
12137ZGN-1061 hold: There are times when shorting approval/buying a clinical hold istuck-1/17/2019
12136That was interesting to me. Would you mind posting the conference website pleasA.J. Mullen-1/17/2019
12135Two molecules in preclinical pipeline, one aimed at Prader-Willy syndrome, the sscaram(o)uche-1/17/2019
12134>> Wow, this was a high flyer at one point. << Once a fave of Feuerscaram(o)uche-1/17/2019
12133Wow, this was a high flyer at one point. I hadn't looked at the chart untilatticus4paws-1/17/2019
12132well ptttttttttffffffffbbbbbbbbt! basis 5.04.scaram(o)uche-1/17/2019
12131Excellent, thanks!scaram(o)uche-1/17/2019
12130I got a quick answer from the company. The 1.1% is placebo-adjusted absolute ratticus4paws-1/17/2019
12129Yup. But interesting..... IND was put on hold, implying that the preclinicalscaram(o)uche-1/17/2019
12128My other question would be how long until the VTE's showed up in the prior gatticus4paws-1/17/2019
12127Worth noting that there were day traders shorting the pre-market gap. Probably scaram(o)uche-1/17/2019
12126ncbi.nlm.nih.gov T2D a more serious indication?scaram(o)uche-1/17/2019
12125Exactly. I'm guessing that they forgot the word "absolute." I&atticus4paws-1/17/2019
12124What's interesting to me, is why they aren't chasing obesity this time atuck-1/17/2019
12123Very difficult to see how they'd get p<0.0001 with (your example) 7% to 6scaram(o)uche-1/17/2019
12122urrrrrrrrrrrgh.............. it does read "with a 1.1% reduction in A1C scaram(o)uche-1/17/2019
12121Thanks! I saw the news on twitter this morning and had to go look up what MetAPatticus4paws-1/17/2019
12120Only about 30 minutes of updating knowledge re. a company that I've bashed..scaram(o)uche-1/17/2019
12119>> Don't be surprised if I come back to this with some attempts at exascaram(o)uche-1/16/2019
12118>> AXGN << Never owned it, never looked closely. Today, CCO gets ascaram(o)uche-1/16/2019
12117Interesting little thread/concept on preclinical publications. This guy uses ittuck-1/16/2019
12116Getting paid for again, so no surprise it resumed its trajectory. ASP +6%, docs rkrw-1/15/2019
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News